AZYO News and Press, Aziyo Biologics Inc. From 03/22/23

2023-03-22 18:12:04 ET Aziyo Biologics, Inc. (AZYO) Q4 2022 Earnings Conference Call March 22, 2023, 04:30 PM ET Company Participants Matt Steinberg - Investor Relations, FINN Partners Randy Mills - Chief Executive Officer Matt Ferguson - Chief Financial Officer ...

2023-03-22 16:32:08 ET Aziyo Biologics press release ( NASDAQ: AZYO ): Q4 GAAP EPS of -$0.38 beats by $0.34 . Revenue of $12.67M (+16.2% Y/Y) beats by $0.12M . Aziyo’s cash balance as of December 31, 2022 was $17.0 million, which included $10.2 million i...

SILVER SPRING, Md., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today provided a business update and r...

SILVER SPRING, Md. and IRVINE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, and Sientra, Inc. (...

2023-03-20 13:07:07 ET Gainers: Loyalty Ventures ( LYLT ) +97% . Ambipar Emergency ( AMBI ) +73% . Lifecore Biomedical ( LFCR ) +60% . InMed Pharmaceuticals ( INM ) +43% . New York Community Bancorp ( NYCB ) +32% . Harbor Cus...

2023-03-20 10:29:09 ET Gainers: Lifecore Biomedical ( LFCR ) +41% . Connect Biopharma ( CNTB ) +27% . InMed Pharmaceuticals ( INM ) +21% . ReShape Lifesciences ( RSLS ) +21% . Bellerophon Therapeutics ( BLPH ) +15% . Losers...

2023-03-20 09:09:13 ET Aziyo Biologics ( NASDAQ: AZYO ), a biotech focused on regenerative medical products, lost ~56% premarket Monday after announcing that the FDA noted deficiencies in its marketing application for CanGaroo RM Antibacterial Envelope. The issue relat...

SILVER SPRING, Md., March 20, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, provides an update on its submission to the U.S. Food and Drug...

2023-03-19 09:33:58 ET Summary Thinly traded shares of regenerative medicine concern Aziyo Biologics, Inc. fell 40% on a capital raise that diluted shareholders only 17%. The company is unprofitable, but a 1Q23 FDA decision on its next-generation antibiotic eluting sleeve could pr...

SILVER SPRING, Md., March 15, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release i...